σ1 receptors are involved in the visceral pain induced by intracolonic administration of capsaicin in mice

Anesthesiology

Volumn 118, Issue 3, 2013, Pages 691-700

  González Cano, Rafael ^a   Merlos, Manuel ^b   Baeyens, José M ^a   Cendán, Cruz M ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Department of Pharmacology ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; BD 1063; CAPSAICIN; KETOPROFEN; MORPHINE; OPIATE ANTAGONIST; S1RA; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ABDOMINAL WALL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERALGESIA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REFERRED PAIN; VISCERAL PAIN; WILD TYPE;

ANIMALS; CAPSAICIN; COLON; FEMALE; MICE; MICE, KNOCKOUT; PAIN MEASUREMENT; RECEPTORS, SIGMA; VISCERAL PAIN;

EID: 84874654899     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318280a60a     Document Type: Article

References (51)

1. Cervero F, Laird JM: Visceral pain. Lancet 1999; 353:2145-8
2. Wesselmann U, Baranowski AP, Börjesson M, Curran NC, Czakanski PP, Giamberardino MA, Ness TJ, Robbins MT, Traub RJ: Emerging therapies and novel approaches to visceral pain. Drug Discov Today Ther Strateg 2009; 6:89-95
3. Cervero F: Visceral versus somatic pain: Similarities and differences. Dig Dis 2009; 27(suppl 1):3-10
4. Robinson DR, Gebhart GF: Inside information: The unique features of visceral sensation. Mol Interv 2008; 8:242-53
5. Al-Chaer ED, Traub RJ: Biological basis of visceral pain: Recent developments. Pain 2002; 96:221-5
6. Braz JM, Nassar MA, Wood JN, Basbaum AI: Parallel "pain" pathways arise from subpopulations of primary afferent nociceptor. Neuron 2005; 47:787-93
7. Foreman RD: Mechanisms of visceral pain: From nociception to targets. Drug Discov Today Dis Mech 2004; 1:457-63
8. Lu J, Zhou XF, Rush RA: Small primary sensory neurons innervating epidermis and viscera display differential phenotype in the adult rat. Neurosci Res 2001; 41:355-63
9. Perry MJ, Lawson SN: Differences in expression of oligosaccharides, neuropeptides, carbonic anhydrase and neurofilament in rat primary afferent neurons retrogradely labelled via skin, muscle or visceral nerves. Neuroscience 1998; 85:293-310
10. Strigo IA, Bushnell MC, Boivin M, Duncan GH: Psychophysical analysis of visceral and cutaneous pain in human subjects. Pain 2002; 97:235-46
11. Laird JM, Martinez-Caro L, Garcia-Nicas E, Cervero F: A new model of visceral pain and referred hyperalgesia in the mouse. Pain 2001; 92:335-42
12. Kawao N, Ikeda H, Kitano T, Kuroda R, Sekiguchi F, Kataoka K, Kamanaka Y, Kawabata A: Modulation of capsaicin-evoked visceral pain and referred hyperalgesia by protease-activated receptors 1 and 2. J Pharmacol Sci 2004; 94:277-85
13. Arendt-Nielsen L, Schipper KP, Dimcevski G, Sumikura H, Krarup AL, Giamberardino MA, Drewes AM: Viscero-somatic reflexes in referred pain areas evoked by capsaicin stimulation of the human gut. Eur J Pain 2008; 12:544-51
14. Drewes AM, Schipper KP, Dimcevski G, Petersen P, Gregersen H, Funch-Jensen P, Arendt-Nielsen L: Gut pain and hyperalgesia induced by capsaicin: A human experimental model. Pain 2003; 104:333-41
15. Schmidt B, Hammer J, Holzer P, Hammer HF: Chemical nociception in the jejunum induced by capsaicin. Gut 2004; 53:1109-16
16. Cobos EJ, Entrena JM, Nieto FR, Cendán CM, Del Pozo E: Pharmacology and therapeutic potential of sigma(1) receptor ligands. Curr Neuropharmacol 2008; 6:344-66
17. Maurice T, Su TP: The pharmacology of sigma-1 receptors. Pharmacol Ther 2009; 124:195-206
18. Alonso G, Phan V, Guillemain I, Saunier M, Legrand A, Anoal M, Maurice T: Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 2000; 97:155-70
19. Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R: Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat 2000; 20:375-87
20. Cendán CM, Pujalte JM, Portillo-Salido E, Montoliu L, Baeyens JM: Formalin-induced pain is reduced in sigma(1) receptor knockout mice. Eur J Pharmacol 2005; 511:73-4
21. De la Puente B, Nadal X, Portillo-Salido E, Sánchez-Arroyos R, Ovalle S, Palacios G, Muro A, Romero L, Entrena JM, Baeyens JM, López-García JA, Maldonado R, Zamanillo D, Vela JM: Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury. Pain 2009; 145:294-303
22. Entrena JM, Cobos EJ, Nieto FR, Cendán CM, Gris G, Del Pozo E, Zamanillo D, Baeyens JM: Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice. Pain 2009; 143:252-61
23. Cendán CM, Pujalte JM, Portillo-Salido E, Baeyens JM: Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice. Psychopharmacology (Berl) 2005; 182:485-93
24. Entrena JM, Cobos EJ, Nieto FR, Cendán CM, Baeyens JM, Del Pozo E: Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: Role of sigma-1 receptors. Psychopharmacology (Berl) 2009; 205:21-33
25. Kim HW, Kwon YB, Roh DH, Yoon SY, Han HJ, Kim KW, Beitz AJ, Lee JH: Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice. Br J Pharmacol 2006; 148:490-8
26. Roh DH, Kim HW, Yoon SY, Seo HS, Kwon YB, Kim KW, Han HJ, Beitz AJ, Na HS, Lee JH: Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain. Anesthesiology 2008; 109:879-89
27. Romero L, Zamanillo D, Nadal X, Sánchez-Arroyos R, Rivera-Arconada I, Dordal A, Montero A, Muro A, Bura A, Segalés C, Laloya M, Hernández E, Portillo-Salido E, Escriche M, Codony X, Encina G, Burgueño J, Merlos M, Baeyens JM, Giraldo J, López-García JA, Maldonado R, Plata-Salamán CR, Vela JM: Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization. Br J Pharmacol 2012; 166:2289-306
28. Son JS, Kwon YB: Sigma-1 receptor antagonist BD1047 reduces allodynia and spinal ERK phosphorylation following chronic compression of dorsal root ganglion in rats. Korean J Physiol Pharmacol 2010; 14:359-64
29. Nieto FR, Cendán CM, Sánchez-Fernández C, Cobos EJ, Entrena JM, Tejada MA, Zamanillo D, Vela JM, Baeyens JM: Role of sigma-1 receptors in Paclitaxel-induced neuropathic pain in mice. J Pain 2012; 13:1107-21
30. Nakazato A, Kumagai T, Ohta K, Chaki S, Okuyama S, Tomisawa K: Synthesis and SAR of 1-alkyl-2-phenylethylamine derivatives designed from N,N-dipropyl-4-methoxy-3-(2-phenylethoxy)phenylethylamine to discover sigma(1) ligands. J Med Chem 1999; 42:3965-70
31. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53:55-63
32. Dixon WJ: Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980; 20:441-62
33. Laird JM, Souslova V, Wood JN, Cervero F: Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. J Neurosci 2002; 22:8352-6
34. Cervero F, Laird JMA: Spinal mechanisms of visceral pain and hyperalgesia, Synaptic Plasticity in Pain. Edited by Malcangio M. New York, Springer Science Business Media, 2009, pp 289-306
35. Christianson JA, Traub RJ, Davis BM: Differences in spinal distribution and neurochemical phenotype of colonic afferents in mouse and rat. J Comp Neurol 2006; 494:246-59
36. Christianson JA, McIlwrath SL, Koerber HR, Davis BM: Transient receptor potential vanilloid 1-immunopositive neurons in the mouse are more prevalent within colon afferents compared to skin and muscle afferents. Neuroscience 2006; 140:247-57
37. Robinson DR, McNaughton PA, Evans ML, Hicks GA: Characterization of the primary spinal afferent innervation of the mouse colon using retrograde labelling. Neurogastroenterol Motil 2004; 16:113-24
38. Mansikka H, Lähdesmäki J, Scheinin M, Pertovaara A: Alpha(2A) adrenoceptors contribute to feedback inhibition of capsaicin-induced hyperalgesia. Anesthesiology 2004; 101:185-90
39. Díaz JL, Zamanillo D, Corbera J, Baeyens JM, Maldonado R, Pericàs MA, Vela JM, Torrens A: Selective sigma-1 (sigma1) receptor antagonists: Emerging target for the treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem 2009; 9:172-83
40. Gingrich JA, Hen R: The broken mouse: The role of development, plasticity and environment in the interpretation of phenotypic changes in knockout mice. Curr Opin Neurobiol 2000; 10:146-52
41. Voss LJ, Melin S, Jacobson G, Sleigh JW: GABAergic compensation in connexin36 knock-out mice evident during low-magnesium seizure-like event activity. Brain Res 2010; 1360:49-55
42. Min R, Di Marzo V, Mansvelder HD: DAG lipase involvement in depolarization-induced suppression of inhibition: Does endocannabinoid biosynthesis always meet the demand? Neuroscientist 2010; 16:608-13
43. Guscott M, Bristow LJ, Hadingham K, Rosahl TW, Beer MS, Stanton JA, Bromidge F, Owens AP, Huscroft I, Myers J, Rupniak NM, Patel S, Whiting PJ, Hutson PH, Fone KC, Biello SM, Kulagowski JJ, McAllister G: Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 2005; 48:492-502
44. Bonin RP, Labrakakis C, Eng DG, Whissell PD, De Koninck Y, Orser BA: Pharmacological enhancement of δ-subunitcontaining GABA(A) receptors that generate a tonic inhibitory conductance in spinal neurons attenuates acute nociception in mice. Pain 2011; 152:1317-26
45. Girard P, Verniers D, Coppé MC, Pansart Y, Gillardin JM: Nefopam and ketoprofen synergy in rodent models of antinociception. Eur J Pharmacol 2008; 584:263-71
46. Mitrovic M, Shahbazian A, Bock E, Pabst MA, Holzer P: Chemo-nociceptive signalling from the colon is enhanced by mild colitis and blocked by inhibition of transient receptor potential ankyrin 1 channels. Br J Pharmacol 2010; 160:1430-42
47. Shin JW, Hwang KS, Kim YK, Leem JG, Lee C: Nonsteroidal antiinflammatory drugs suppress pain-related behaviors, but not referred hyperalgesia of visceral pain in mice. Anesth Analg 2006; 102:195-200
48. Chien CC, Pasternak GW: Functional antagonism of morphine analgesia by (+)-pentazocine: Evidence for an antiopioid sigma 1 system. Eur J Pharmacol 1993; 250:R7-8
49. Chien CC, Pasternak GW: Selective antagonism of opioid analgesia by a sigma system. J Pharmacol Exp Ther 1994; 271:1583-90
50. Mei J, Pasternak GW: Sigma1 receptor modulation of opioid analgesia in the mouse. J Pharmacol Exp Ther 2002; 300:1070-4
51. Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S: Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008; 57:923-9